(JAZZ) Jazz Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jazz Pharmaceuticals | (JAZZ) share price targets
Complete technical analysis of Jazz Pharmaceuticals (JAZZ) by charts plus indicators, forecast predictions and share price targets for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-13 View latest technical analysis
10 day averaged volume of Jazz Pharmaceuticals is 1058876
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Thu Mar 2025 | 136.05 | 135.80 | 138.33 | 135.07 | 1 times |
| 12 Wed Mar 2025 | 134.16 | 136.77 | 137.51 | 133.99 | 0.724 times |
| 11 Tue Mar 2025 | 136.86 | 136.84 | 138.59 | 134.62 | 0.86 times |
| 10 Mon Mar 2025 | 137.45 | 138.19 | 140.27 | 136.48 | 1.159 times |
| 07 Fri Mar 2025 | 138.81 | 139.18 | 141.36 | 137.33 | 1.158 times |
| 06 Thu Mar 2025 | 136.39 | 138.27 | 140.13 | 135.36 | 1.039 times |
| 05 Wed Mar 2025 | 140.23 | 139.28 | 142.93 | 137.62 | 1.028 times |
| 04 Tue Mar 2025 | 138.95 | 139.43 | 141.28 | 138.23 | 0.841 times |
| 03 Mon Mar 2025 | 140.22 | 144.25 | 145.40 | 139.60 | 0.911 times |
| 28 Fri Feb 2025 | 143.53 | 142.31 | 143.67 | 140.89 | 1.128 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 135.1 as stoploss in an intra day buy trade for a target of 138.01. However, stock will show a bearish move below 135.1.
Share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Target | 108.74 |
| Downside Target | 117.80 |
| Downside Target | 127.10 |
| Downside Target | 132.58 |
| Downside Target | 135.36 |
| Upside Target | 137.60 |
| Upside Target | 138.27 |
| Upside Target | 140.27 |
| Upside Target | 145.40 |
| Upside Target | 148.06 |
Intraday share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Intraday Target | 133.27 |
| Downside Intraday Target | 130.49 |
| Upside Intraday Target | 139.55 |
| Upside Intraday Target | 143.05 |
| Upside Intraday Target | 136.77 |
Weekly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Thu Mar 2025 | 136.05 | 138.19 | 140.27 | 133.99 | 0.752 times |
| 07 Fri Mar 2025 | 138.81 | 144.25 | 145.40 | 135.36 | 0.714 times |
| 28 Fri Feb 2025 | 143.53 | 137.00 | 148.06 | 134.00 | 3.078 times |
| 21 Fri Feb 2025 | 136.01 | 134.00 | 137.60 | 132.58 | 0.412 times |
| 14 Fri Feb 2025 | 133.96 | 121.00 | 138.27 | 120.90 | 2.377 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Thu Mar 2025 | 136.05 | 144.25 | 145.40 | 133.99 | 0.512 times |
| 28 Fri Feb 2025 | 143.53 | 122.31 | 148.06 | 119.12 | 1.651 times |
| 31 Fri Jan 2025 | 124.37 | 123.43 | 127.14 | 118.72 | 1.078 times |
| 31 Tue Dec 2024 | 123.15 | 122.94 | 127.10 | 117.80 | 0.698 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Jazz Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Jazz Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 138.43 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Jazz Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Jazz Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 138.43 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.